Pressure BioSciences, Inc.
PBIO · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 14.4% | -13.6% | 64% | – |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | 40.4% | -16.5% | 52.9% | 52.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -474.8% | -312.5% | -276.1% | -611% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,482.2% | -929.6% | -1,006.5% | -1,311.3% |
| EPS Diluted | -1.51 | -1.61 | -3.42 | -5.32 |
| % Growth | 6.2% | 52.9% | 35.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |